Mr Navaneethan Palanisamy, B.Tech., M.MedSc., M.Sc. - University of Heidelberg

Mr Navaneethan Palanisamy

B.Tech., M.MedSc., M.Sc.

University of Heidelberg

Heidelberg, Baden Würtumberg | Germany

ORCID logohttps://orcid.org/0000-0003-0369-2316

Mr Navaneethan Palanisamy, B.Tech., M.MedSc., M.Sc. - University of Heidelberg

Mr Navaneethan Palanisamy

B.Tech., M.MedSc., M.Sc.

Introduction

Primary Affiliation: University of Heidelberg - Heidelberg, Baden Würtumberg , Germany

Metrics

Number of Publications

18

Publications

Number of Profile Views

2096

Profile Views

Number of Article Reads

412

Reads

Number of PubMed Central Citations

50

PubMed Central Citations

Education

Sep 2012 - May 2014
Georg August Universität Gottingen
Master of Science
Aug 2010 - Jun 2012
Uppsala Universitet
Master of Medical Science
Jun 2006 - May 2010
VIT University
Bachelor of Technology

Experience

Apr 2014 - Oct 2014
Max-Planck-Institut für biophysikalische Chemie
Research Assistant
Jun 2010 - Jul 2010
Institute for Social and Economic Change
Technical Assistant

Top co-authors

Dario Akaberi
Dario Akaberi

Section of Clinical Microbiology

4
Chakradhar Kokkula
Chakradhar Kokkula

Uppsala University

2
Ake Lundkvist
Ake Lundkvist

Swedish Institute for Infectious Disease Control

2
Nathan Osman
Nathan Osman

Jewish General Hospital

2
Mark A Wainberg
Mark A Wainberg

Jewish General Hospital

2
Axel Danielsson
Axel Danielsson

Uppsala University

2
Hong-Tao Xu
Hong-Tao Xu

China Medical University

2

Publications

18Publications

412Reads

50PubMed Central Citations

Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the approach.

Infect Ecol Epidemiol 2018 5;8(1):1528117. Epub 2018 Oct 5.

Clinical Microbiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article
October 2018
2 Reads

Identification of putative drug targets and annotation of unknown proteins in Tropheryma whipplei.

Comput Biol Chem 2018 Oct 9;76:130-138. Epub 2018 Jun 9.

Molecular and Cellular Engineering Group, BioQuant, University of Heidelberg, Heidelberg, Germany; The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS), University of Heidelberg, Heidelberg, Germany. Electronic address:

View Article
October 2018
19 Reads
1.12 Impact Factor

Deleterious single nucleotide polymorphisms of protein kinase R identified by the computational approach.

Mol Immunol 2018 Sep 4;101:65-73. Epub 2018 Jun 4.

Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany; HBIGS, University of Heidelberg, Heidelberg, Germany; Institute of Biology II, University of Freiburg, Freiburg, Germany. Electronic address:

View Article
September 2018
17 Reads
2.97 Impact Factor

Comparative genome analysis of Alkhumra hemorrhagic fever virus with Kyasanur forest disease and tick-borne encephalitis viruses by the in silico approach.

Pathog Glob Health 2018 Jun 10;112(4):210-226. Epub 2018 May 10.

d Department of Medical Biochemistry and Microbiology, Zoonosis Science Center , Uppsala University , Uppsala , Sweden.

View Article
June 2018
22 Reads
0.84 Impact Factor

Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals.

Antivir Ther 2018 May 10. Epub 2018 May 10.

Clinical Microbiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article
May 2018
26 Reads
1 PubMed Central Citation(source)
3.02 Impact Factor

Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.

Interdiscip Sci 2018 Mar 16;10(1):143-156. Epub 2016 Jun 16.

Section of Clinical Virology, Department of Medical Sciences, Uppsala University, 751 85, Uppsala, Sweden.

View Article
March 2018
39 Reads

Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus.

Mol Phylogenet Evol 2018 01 22;118:58-63. Epub 2017 Sep 22.

Section of Clinical Microbiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article
January 2018
23 Reads
3.92 Impact Factor

Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication.

Sci Rep 2017 Jul 24;7(1):6345. Epub 2017 Jul 24.

McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

View Article
July 2017
27 Reads
2 PubMed Central Citations(source)
5.08 Impact Factor

Computational Prediction of Usutu Virus E Protein B Cell and T Cell Epitopes for Potential Vaccine Development.

Scand J Immunol 2017 May;85(5):350-364

Section of Clinical Virology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article
May 2017
24 Reads
1.88 Impact Factor

Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study.

AIDS Res Ther 2017 Jan 7;14(1). Epub 2017 Jan 7.

McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755, Ch. Cote-Ste-Catherine, Montréal, QC, Canada.

View Article
January 2017
31 Reads
2 PubMed Central Citations(source)
1.84 Impact Factor

SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase.

Mol Biotechnol 2016 Oct;58(10):619-625

Section of Virology, Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 17, 75185, Uppsala, Sweden.

View Article
October 2016
34 Reads
1.88 Impact Factor

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden.

Infect Dis (Lond) 2015 Aug 8;47(8):555-62. Epub 2015 Apr 8.

From the 1 Clinical Virology, Department of Medical Sciences, Uppsala University , Uppsala.

View Article
August 2015
40 Reads
7 PubMed Central Citations(source)

Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.

PLoS One 2014 19;9(5):e97695. Epub 2014 May 19.

Infection Biology Unit, German Primate Center, Göttingen, Germany.

View Article
January 2015
39 Reads
18 PubMed Central Citations(source)
3.23 Impact Factor

Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden.

Infect Ecol Epidemiol 2014 Jan 15;4. Epub 2014 Jan 15.

Section of Clinical Virology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article
January 2014
34 Reads
2 PubMed Central Citations(source)

Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a.

Antiviral Res 2013 Jul 3;99(1):12-7. Epub 2013 May 3.

Clinical Virology, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden.

View Article
July 2013
35 Reads
18 PubMed Central Citations(source)
3.94 Impact Factor

Top co-authors

Dario Akaberi
Dario Akaberi

Section of Clinical Microbiology

4
Chakradhar Kokkula
Chakradhar Kokkula

Uppsala University

2
Ake Lundkvist
Ake Lundkvist

Swedish Institute for Infectious Disease Control

2
Nathan Osman
Nathan Osman

Jewish General Hospital

2
Mark A Wainberg
Mark A Wainberg

Jewish General Hospital

2
Axel Danielsson
Axel Danielsson

Uppsala University

2
Hong-Tao Xu
Hong-Tao Xu

China Medical University

2

Followers